NASDAQ:PBLS Parabilis Medicines Q2 2026 Earnings Results & Report $26.85 -2.10 (-7.25%) As of 10/13/2026 04:00 PM Eastern Parabilis Medicines missed analyst earnings expectations in its Q2 2026 results, released August 13, 2026. The company reported EPS of -$2.32 versus the -$0.16 consensus estimate, while revenue was $0.15 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 13, 2026TimeBefore Market OpensConference Call7:00 AM ET Parabilis Medicines EPS ResultsActual EPS-$2.32Consensus EPS -$0.16Beat/MissMissed by -$2.16One Year Ago EPSN/AParabilis Medicines Revenue ResultsActual Revenue$0.15 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Parabilis Medicines Q2 2026 Earnings FAQ Did Parabilis Medicines beat earnings estimates for Q2 2026? Parabilis Medicines (NASDAQ:PBLS) reported earnings of -$2.32 per share for Q2 2026, missing the consensus estimate of -$0.16. The report was announced on Thursday, August 13, 2026. What was Parabilis Medicines' revenue for Q2 2026? Parabilis Medicines reported revenue of $0.15 million for Q2 2026. Parabilis Medicines Earnings HeadlinesParabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis2 hours ago | globenewswire.comParabilis Medicines Inc (PBLS)September 23, 2026 | investing.comI have publicly predicted six major American crashes, before each one happened.Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.October 14 at 1:00 AM | Weiss Ratings (Ad)Parabilis Medicines, Inc. (PBLS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeptember 16, 2026 | seekingalpha.comParabilis Medicines Inc PBLSSeptember 10, 2026 | morningstar.comMParabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare ConferenceSeptember 1, 2026 | globenewswire.comSee More Parabilis Medicines Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Parabilis Medicines? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Parabilis Medicines and other key companies, straight to your email. Email Address About Parabilis MedicinesParabilis Medicines (NASDAQ:PBLS) is a biopharmaceutical company focused on discovering and developing medicines for patients with serious diseases. The company’s activities include advancing novel therapeutic candidates through preclinical research and clinical development. Publicly available information about Parabilis Medicines is limited, and specific details regarding its product portfolio, lead development programs, geographic operations and executive leadership are not sufficiently established to describe them accurately.View Parabilis Medicines ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American BusinessTax Credit Turmoil: Why Enphase and SolarEdge Face a Tough RoadSurgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based StrengthAmazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?Venezuela's Oil Revival Is Gaining Momentum—3 Energy Stocks Positioned to Benefit Upcoming Earnings Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026)U.S. Bancorp (10/15/2026)Prologis (10/15/2026)Taiwan Semiconductor Manufacturing (10/15/2026)Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
